Skip to main content
Vai all'homepage della Commissione europea (si apre in una nuova finestra)
italiano it
CORDIS - Risultati della ricerca dell’UE
CORDIS

BIO-PHOTONIC IMAGING OF THE INFANT BRAIN, THE MISSING LINK BETWEEN THE CELLULAR BRAIN DAMAGE AND THE NEUROVASCULAR UNIT DURING ACUTE ILLNESS

Descrizione del progetto

Uno strumento per l’immaginografia del cervello infantile

I difetti cardiaci congeniti (CHD, Congenital Heart Defects) sono difetti di nascita che possono influire sulla struttura e sulla funzione cardiache. Nonostante gli interventi chirurgici abbiano migliorato il tasso di sopravvivenza dei pazienti affetti da difetti cardiaci congeniti, la lesione cerebrale provoca problemi dello sviluppo neurologico. Il campo di applicazione del progetto TinyBrains, finanziato dall’UE, prevede di affrontare i limiti tecnici legati all’immaginografia del cervello infantile e di chiarire le origini cellulari della lesione cerebrale nei pazienti affetti da difetti cardiaci congeniti. Gli scienziati svilupperanno uno strumento di ricerca basato su tecnologie biofotoniche e sull’elettroencefalografia, al fine di valutare il metabolismo dell’ossigeno, l’elettrofisiologia e altri parametri del cervello affetto da difetti cardiaci congeniti. Al tempo stesso, il dispositivo di immaginografia di TinyBrains agevolerà la ricerca di terapie e strategie di gestione inedite.

Obiettivo

The brain of the newborn is very different from the adult posing a major problem in assessing the origins of its injuries and in developing therapeutics. This is further complicated when the newborn was born prematurely or its in-utero development has been compromised. In these situations, their interplay between contributing factors become complex to understand with current tools since they are technically and ethically difficult to employ widely. TinyBrains will develop a neuro-imager and focus on congenital heart-defects (CHD). CHD is the most prevalent congenital malformation with about a million births worldwide annually. Advances in surgical techniques and perioperative management have dramatically reduced mortality rates with more than 85% surviving to adulthood. However, significant neurodevelopmental problems are observed in about 50% due to brain injury. It being so prevalent and also having accepted accionable points in its care and therapy, TinyBrains chose CHD as its target to provide a research platform to improve the understanding of the cellular origin of the brain injury by enabling the assessment of the link between energy demand and oxygen supply. To so, we will combine advanced biophotonics technologies and electroencephalography into a disruptive research tool enabling research into new brain-oriented therapies and management strategies. TinyBrains will measure cerebral hemodynamics, oxygen metabolism and electrophysiology simultaneously. In vivo imaging in three-dimensions, i.e. tomography, will greatly increase the brain specificity and penetration as well as, for the first time, providing spatial resolution to this class of measurements. This plethora of information will enable us to carry out pre-clinical animal and clinical studies in infants with and without CHD to gain a peek at the cellular origins of brain injury. By bringing together academia, clinics and industry, TinyBrains further seeks to create the path for exploitation.

Campo scientifico (EuroSciVoc)

Parole chiave

Programma(i)

Argomento(i)

Meccanismo di finanziamento

RIA - Research and Innovation action

Vedi tutti i progetti finanziati nell’ambito di questo schema di finanziamento

Invito a presentare proposte

(si apre in una nuova finestra) H2020-ICT-2018-20

Vedi tutti i progetti finanziati nell’ambito del bando

Coordinatore

FUNDACIO INSTITUT DE CIENCIES FOTONIQUES
Contributo netto dell'UE
€ 1 103 033,46
Indirizzo
AVINGUDA CARL FRIEDRICH GAUSS 3
08860 Castelldefels
Spagna
Regione
Este Cataluña Barcelona
Tipo di attività
Research Organisations
Collegamenti
Costo totale
€ 1 103 033,46

Partecipanti (6)